# Lecanemab Analysis

<h3 align="right">Colby T. Ford, Ph.D.</h3>

Analyses of Lecanemab, an amyloid beta-targeting antibody used to treat Alzheimerâ€™s Disease.


## References
- KEGG Entry: https://www.kegg.jp/entry/D11678
- DrugBank Entry: https://go.drugbank.com/drugs/DB14580
- Stern et al., 2023: https://doi.org/10.1016/j.neuron.2023.04.007
